UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug delivery strategy in hepatocellular carcinoma therapy

Cell communication and signaling, 2022-03, Vol.20 (1), p.26-26, Article 26

2022

Volltextzugriff (PDF)

Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review

Frontiers in medicine, 2022-08, Vol.9, p.934989

2022

Volltextzugriff (PDF)

Tenofovir Disoproxil Fumarate Is Superior to Entecavir in Reducing Hepatitis B Surface Antigen for Chronic Hepatitis B in China: 2-Year Comprehensive Comparative Result of a Matched Comparative Study

Frontiers in medicine, 2021-03, Vol.8, p.637126-637126

2021

Volltextzugriff (PDF)

The Mechanism of APOBEC3B in Hepatitis B Virus Infection and HBV Related Hepatocellular Carcinoma Progression, Therapeutic and Prognostic Potential

Infection and drug resistance, 2024-01, Vol.17, p.4477-4486

2024

Volltextzugriff (PDF)

Dynamic analysis of coherent fault trees

Journal of quality in maintenance engineering, 1998-06, Vol.4 (2), p.122-130

1998

Volltextzugriff (PDF)

Discovery of STAT3 Inhibitors: Recent Advances and Future Perspectives

Current medicinal chemistry, 2023-01, Vol.30 (16), p.1824-1847

2023

Volltextzugriff (PDF)

Recent Progress on the Discovery of NLRP3 Inhibitors and their Therapeutic Potential

Current medicinal chemistry, 2021-01, Vol.28 (3), p.569-582

2021

Volltextzugriff (PDF)

Therapeutic potential of fucosyltransferases in cancer and recent development of targeted inhibitors

Drug discovery today, 2023-01, Vol.28 (1), p.103394-103394, Article 103394

2023

Volltextzugriff (PDF)

tRNA-Derived Fragment tRF-Glu-TTC-027 Regulates the Progression of Gastric Carcinoma via MAPK Signaling Pathway

Frontiers in oncology, 2021-08, Vol.11, p.733763-733763

2021

Volltextzugriff (PDF)

Advances in the Therapeutic Potential of Inhibitors Targeting Glycogen Synthase Kinase 3 in Inflammatory Diseases

Mini reviews in medicinal chemistry, 2023-01, Vol.23 (19), p.1893-1904

2023

Volltextzugriff (PDF)

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

The lancet oncology, 2021-08, Vol.22 (8), p.1081-1092

2021

Volltextzugriff (PDF)

Corrigendum to “Therapeutic potential of fucosyltransferases in cancer and recent development of targeted inhibitors” [Drug Discov. Today 28(1) (2023) 103394]

Drug discovery today, 2023-03, Vol.28 (3), p.103484-103484, Article 103484

2023

Volltextzugriff (PDF)

Reaction-Based “Off–On” Fluorescent Probe Enabling Detection of Endogenous Labile Fe2+ and Imaging of Zn2+-induced Fe2+ Flux in Living Cells and Elevated Fe2+ in Ischemic Stroke

Bioconjugate chemistry, 2016-02, Vol.27 (2), p.302-308

2016

Volltextzugriff (PDF)

Targeting P2Y14R protects against necroptosis of intestinal epithelial cells through PKA/CREB/RIPK1 axis in ulcerative colitis

Nature communications, 2024-03, Vol.15 (1), p.2083-2083, Article 2083

2024

Volltextzugriff (PDF)

γ-AApeptides as a New Class of Peptidomimetics: Design, Synthesis, and Applications

Current topics in medicinal chemistry, 2021-01, Vol.21 (28), p.2574-2592

2021

Volltextzugriff (PDF)

tRF-Val-CAC-016 modulates the transduction of CACNA1d-mediated MAPK signaling pathways to suppress the proliferation of gastric carcinoma

Cell communication and signaling, 2022-05, Vol.20 (1), p.68-68, Article 68

2022

Volltextzugriff (PDF)

A novel SRSF3 inhibitor, SFI003, exerts anticancer activity against colorectal cancer by modulating the SRSF3/DHCR24/ROS axis

Cell death discovery, 2022-05, Vol.8 (1), p.238-238, Article 238

2022

Volltextzugriff (PDF)

FDW028, a novel FUT8 inhibitor, impels lysosomal proteolysis of B7-H3 via chaperone-mediated autophagy pathway and exhibits potent efficacy against metastatic colorectal cancer

Cell death & disease, 2023-08, Vol.14 (8), p.495-495, Article 495

2023

Volltextzugriff (PDF)

Prediction of Drug‐Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches

Chemical biology & drug design, 2024-08, Vol.104 (2), p.e14607-n/a

2024

Volltextzugriff (PDF)

Discovery and computational studies of 2-phenyl-benzoxazole acetamide derivatives as promising P2Y14R antagonists with anti-gout potential

European journal of medicinal chemistry, 2022-01, Vol.227, p.113933-113933, Article 113933

2022

Volltextzugriff (PDF)

Development of novel NLRP3-XOD dual inhibitors for the treatment of gout

Bioorganic & medicinal chemistry letters, 2020-02, Vol.30 (4), p.126944-126944, Article 126944

2020

Volltextzugriff (PDF)

Discovery of Selective P2Y 6 R Antagonists with High Affinity and In Vivo Efficacy for Inflammatory Disease Therapy

Journal of medicinal chemistry, 2023-05, Vol.66 (9), p.6315-6332

2023

Volltextzugriff (PDF)

Discovery of Selective P2Y6R Antagonists with High Affinity and In Vivo Efficacy for Inflammatory Disease Therapy

Journal of medicinal chemistry, 2023-05, Vol.66 (9), p.6315-6332

2023

Volltextzugriff (PDF)

Discovery of novel and potent P2Y14R antagonists via structure-based virtual screening for the treatment of acute gouty arthritis

Journal of advanced research, 2020-05, Vol.23, p.133-142

2020

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(51)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Drug delivery strategy in hepatocellular carcinoma therapy

Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review

Tenofovir Disoproxil Fumarate Is Superior to Entecavir in Reducing Hepatitis B Surface Antigen for Chronic Hepatitis B in China: 2-Year Comprehensive Comparative Result of a Matched Comparative Study

The Mechanism of APOBEC3B in Hepatitis B Virus Infection and HBV Related Hepatocellular Carcinoma Progression, Therapeutic and Prognostic Potential

Dynamic analysis of coherent fault trees

Discovery of STAT3 Inhibitors: Recent Advances and Future Perspectives

Recent Progress on the Discovery of NLRP3 Inhibitors and their Therapeutic Potential

Therapeutic potential of fucosyltransferases in cancer and recent development of targeted inhibitors

tRNA-Derived Fragment tRF-Glu-TTC-027 Regulates the Progression of Gastric Carcinoma via MAPK Signaling Pathway

Advances in the Therapeutic Potential of Inhibitors Targeting Glycogen Synthase Kinase 3 in Inflammatory Diseases

Corrigendum to “Therapeutic potential of fucosyltransferases in cancer and recent development of targeted inhibitors” [Drug Discov. Today 28(1) (2023) 103394]

Reaction-Based “Off–On” Fluorescent Probe Enabling Detection of Endogenous Labile Fe2+ and Imaging of Zn2+-induced Fe2+ Flux in Living Cells and Elevated Fe2+ in Ischemic Stroke

Targeting P2Y14R protects against necroptosis of intestinal epithelial cells through PKA/CREB/RIPK1 axis in ulcerative colitis

γ-AApeptides as a New Class of Peptidomimetics: Design, Synthesis, and Applications

tRF-Val-CAC-016 modulates the transduction of CACNA1d-mediated MAPK signaling pathways to suppress the proliferation of gastric carcinoma

A novel SRSF3 inhibitor, SFI003, exerts anticancer activity against colorectal cancer by modulating the SRSF3/DHCR24/ROS axis

FDW028, a novel FUT8 inhibitor, impels lysosomal proteolysis of B7-H3 via chaperone-mediated autophagy pathway and exhibits potent efficacy against metastatic colorectal cancer

Prediction of Drug‐Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches

The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial

Discovery and computational studies of 2-phenyl-benzoxazole acetamide derivatives as promising P2Y14R antagonists with anti-gout potential

Development of novel NLRP3-XOD dual inhibitors for the treatment of gout

Discovery of Selective P2Y 6 R Antagonists with High Affinity and In Vivo Efficacy for Inflammatory Disease Therapy

Discovery of Selective P2Y6R Antagonists with High Affinity and In Vivo Efficacy for Inflammatory Disease Therapy

Discovery of novel and potent P2Y14R antagonists via structure-based virtual screening for the treatment of acute gouty arthritis

Suchergebnisse filtern